In vivo quantification of myocardial dihydropyridine binding sites: A PET study in dogs

Journal of Nuclear Medicine

Volumn 43, Issue 9, 2002, Pages 1227-1233

  Valette, Héric ^a   Dollé, Frédéric ^a   Guenther, Ilonka ^a   Fuseau, Chantal ^a   Coulon, Christine ^a   Hinnen, Françoise ^a   Péglion, Jean Louis ^a   Crouzel, Christian ^a  

^a DIF   (France)

Author keywords

11C S12968; Dihydropyridine binding; Heart; PET

Indexed keywords

2 [[2 (2 AMINOETHOXY)ETHOXY]METHYL] 4 (2,3 DICHLOROPHENYL) 1,4 DIHYDRO 6 METHYL 3,5 PYRIDINEDICARBOXYLIC ACID 3 ETHYL 5 METHYL ESTER; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; AMLODIPINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CARBON 11; DIHYDROPYRIDINE DERIVATIVE; ISRADIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; NITRENDIPINE; TRITIUM;

ANIMAL MODEL; ARTICLE; BINDING SITE; CARDIOVASCULAR DISEASE; COMPARTMENT MODEL; DOG; DRUG UPTAKE; ENANTIOMER; FEMALE; HEART; HEART MUSCLE BLOOD FLOW; ISOTOPE LABELING; LIGAND BINDING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALS; BINDING SITES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CARBON RADIOISOTOPES; DIHYDROPYRIDINES; DOGS; FEMALE; HEART; MYOCARDIUM; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036735360     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Calcium channel ligands
2. L-type calcium channel abundance and function with cardiac hypertrophy and failure: A review
3. Changes in L-type calcium channel abundance and function during transition to pacing-induced congestive heart failure
4. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. II. Effects on myocyte contractile processes
5. Calcium antagonist receptors in cardiomyopathic hamster: Selective in increase in heart, muscle and brain
6. Endotoxin-induced cardiac depression is associated with decreased cardiac dihydropyridine receptors in rabbits
7. 2+ channels in rat heart
8. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy
9. Expression of dihydropyridine receptor (Ca2+) and calsequestrin genes in the myocardium of patients with end-stage heart failure
10. 11C]nicardipine
11. Synthesis of carbon-11 calcium channels antagonists
12. 11CS11568
13. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists
14. Myocardial kinetics of the enantiomers of the calcium channel inhibitor S11568: A PET study in dogs
15. Synthesis of two optically active calcium channel antagonists labeled with carbon-11 for in vivo cardiac PET imaging
16. Intracellular inorganic ions in cardiac tissue
17. Experimental design optimization: Theory and application to estimation of receptor model parameters using dynamic positron emission tomography
18. 11C] flumazenil studied by PET: Application to a critical study of the equilibrium approaches
19. Concept of reaction volume in the in vivo ligand-receptor model
20. 11C-labelled derivative of S12968: An attempt to image in vivo brain calcium channels
21. Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart
22. A new look at the statistical model identification
23. Multiexponential, multicompartmental and non-compartmental modeling: Data analysis and statistical considerations
24. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method
25. 3H]PN 200 110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart
26. Dihydropyridine receptors are primarily functional L-type calcium channels in rabbit ventricular myocytes
27. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes